Weight-Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks
The Rundown
00:00
GLP-1 Antitrust Suit Explained
Zaid explains Strive Specialties' antitrust suit against Eli Lilly and Novo Nordisk over compounded GLP-1 weight-loss drugs.
Play episode from 02:42
Transcript
